Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 3
2003 4
2004 1
2005 2
2006 2
2007 2
2008 2
2009 6
2010 9
2011 3
2012 7
2013 2
2014 2
2015 5
2016 10
2017 2
2018 8
2019 10
2020 5
2021 9
2022 11
2023 12
2024 15
2025 10
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
[Medical myths in ophthalmology].
Krohne TU. Krohne TU. Ophthalmologe. 2016 Dec;113(12):1009. doi: 10.1007/s00347-016-0358-x. Ophthalmologe. 2016. PMID: 27578314 German. No abstract available.
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial.
Khanani AM, Danzig CJ, Heier JS, Jaffe GJ, Kaiser PK, Lally DR, Patel SS, Vajzovic L, Weng CY, Patel H, Clark J, Desai D, Luo D, Henry E, Holz FG; GATHER2 Trial Investigators. Khanani AM, et al. Ophthalmology. 2026 Apr;133(4):451-465. doi: 10.1016/j.ophtha.2025.12.011. Epub 2025 Dec 15. Ophthalmology. 2026. PMID: 41407269 Free article. Clinical Trial.
[Bilateral Scotomata in COVID-19].
Menghesha L, Grajewski RS, Krohne TU. Menghesha L, et al. Among authors: krohne tu. Klin Monbl Augenheilkd. 2024 May;241(5):653-655. doi: 10.1055/a-2120-7665. Epub 2023 Aug 29. Klin Monbl Augenheilkd. 2024. PMID: 37643737 German. No abstract available.
Erratum zu: Makulaforamen und vitreomakuläre Traktion.
Deutsche Ophthalmologische Gesellschaft e. V. (DOG); Retinologische Gesellschaft e. V. (RG); Berufsverband der Augenärzte Deutschlands e. V. (BVA). Deutsche Ophthalmologische Gesellschaft e. V. (DOG), et al. Ophthalmologie. 2023 Jan;120(Suppl 1):70. doi: 10.1007/s00347-022-01803-3. Ophthalmologie. 2023. PMID: 36652000 German. No abstract available.
[Technical principles of OCT angiography].
Fang PP, Harmening WM, Müller PL, Lindner M, Krohne TU, Holz FG. Fang PP, et al. Among authors: krohne tu. Ophthalmologe. 2016 Jan;113(1):6-13. doi: 10.1007/s00347-015-0184-6. Ophthalmologe. 2016. PMID: 26682903 Review. German.
129 results